Cargando…
Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer
Autores principales: | Song, Xuejiao, Gao, Tiantao, Wang, Ningyu, Feng, Qiang, You, Xinyu, Ye, Tinghong, Lei, Qian, Zhu, Yongxia, Xiong, Menghua, Xia, Yong, Yang, Fangfang, Shi, Yaojie, Wei, Yuquan, Zhang, Lidan, Yu, Luoting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850860/ https://www.ncbi.nlm.nih.gov/pubmed/27128979 http://dx.doi.org/10.1038/srep24893 |
Ejemplares similares
-
Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer
por: Song, Xuejiao, et al.
Publicado: (2016) -
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2016) -
Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2022) -
A Novel Benzothiazole Derivative YLT322 Induces Apoptosis via the Mitochondrial Apoptosis Pathway In Vitro with Anti-Tumor Activity in Solid Malignancies
por: Xuejiao, Song, et al.
Publicado: (2013) -
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
por: Gao, Chao, et al.
Publicado: (2016)